Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02090855 · ClinicalTrials.gov registry record
Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem
A clinical trial, sponsored by GE Healthcare.
- Completed
- Registry status
- 108
- Enrollment target
NCT02090855 is a clinical trial that has completed, run by GE Healthcare. The registered enrollment target is 108 participants.
The verdict
NCT02090855 has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
Data from subjects who had previously been dosed with Flutemetamol (18F) Injection and imaged in Study GE-067-007, and who died on or before 10 June 2013, will be analyzed. The PET brain images previously obtained in Study GE-067-007 will be interpreted visually in randomized by 5 independent readers who are blinded to all other subject information, and the images will be classified as abnormal (positive for abnormal neuritic plaque density) or normal (negative for abnormal neuritic plaque density). The numbers of images in each category will be used to calculate sensitivity and specificity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02090855
The ClinicalTrials.gov registry entry for NCT02090855 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02090855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02090855 about?
NCT02090855 is a clinical study titled "Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem". Data from subjects who had previously been dosed with Flutemetamol (18F) Injection and imaged in Study GE-067-007, and who died on or before 10 June 2013, will be analyzed. The PET brain images previously obtained in Study GE-067-007 will be interpreted visually in randomized by 5 independent reader...
What is the current status of trial NCT02090855?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2013-09. Estimated completion is 2014-02.
Who is sponsoring clinical trial NCT02090855?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.